Literature DB >> 21722209

Lipopolysaccharide-induced tau phosphorylation and kinase activity--modulation, but not mediation, by corticotropin-releasing factor receptors.

Allyson D Roe1, Michael A Staup, Jordi Serrats, Paul E Sawchenko, Robert A Rissman.   

Abstract

Clinical studies suggest that exposure to stress can increase risk for Alzheimer's disease (AD). Although the precise links between stress and vulnerability to develop AD remain uncertain, recent animal work suggests that stress may promote susceptibility to AD pathology by activating tau kinases and inducing tau phosphorylation (tau-P). Our previous findings indicate the differential involvement of corticotropin-releasing factor receptor (CRFR) types 1 and 2 in regulating tau-P in the hippocampus induced by acute restraint, an emotional stressor. To assess the generality of CRFR involvement in stress-induced tau-P and tau kinase activity, the present study extends our investigation to a well-characterized physiological stressor, i.e. immune challenge induced by bacterial lipopolysaccharide (LPS). Acute systemic administration of LPS (100 μg/kg) robustly increased hippocampal (but not isocortical or cerebellar) tau-P, peaking at 40-120 min postinjection and abating thereafter. Assessments of the genotype dependence of this effect yielded results that were distinct from the restraint model. Treatment with LPS increased phosphorylation in wild-type, single and double CRFR knockouts with only subtle variation, which included a reliable exaggeration of tau-P responses in CRFR1-deficient mice. Parallel analyses implicated glycogen synthase kinase-3 and cyclin-dependent kinase-5 as likely cellular mediators of LPS-induced tau-P. Conversely, our data suggest that temperature-dependent fluctuations in tau protein phosphatase 2A (PP2A) may not play a role in this context. Thus, neither the strict CRFR1 dependence of restraint-induced tau-P nor the exaggeration of these responses in CRFR2 null mice generalize to the LPS model. CRFR mediation of stress-induced hippocampal tau-P may be limited to emotional stressors.
© 2011 The Authors. European Journal of Neuroscience © 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722209      PMCID: PMC3148267          DOI: 10.1111/j.1460-9568.2011.07764.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  60 in total

1.  Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.

Authors:  C X Gong; T Lidsky; J Wegiel; L Zuck; I Grundke-Iqbal; K Iqbal
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

2.  Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups.

Authors:  C V Dayas; K M Buller; J W Crane; Y Xu; T A Day
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

Review 3.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

4.  Regulation of tau pathology by the microglial fractalkine receptor.

Authors:  Kiran Bhaskar; Megan Konerth; Olga N Kokiko-Cochran; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Neuron       Date:  2010-10-06       Impact factor: 17.173

5.  Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.

Authors:  E Planel; K Yasutake; S C Fujita; K Ishiguro
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

6.  Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

Authors:  Tracy L Bale; Roberto Picetti; Angelo Contarino; George F Koob; Wylie W Vale; Kuo-Fen Lee
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

7.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

Authors:  T L Bale; A Contarino; G W Smith; R Chan; L H Gold; P E Sawchenko; G F Koob; W W Vale; K F Lee
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

8.  Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.

Authors:  M Bennecib; C X Gong; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  2000-11-17       Impact factor: 4.124

9.  Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.

Authors:  Mary J Savage; Yin-Guo Lin; John R Ciallella; Dorothy G Flood; Richard W Scott
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

10.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.

Authors:  K Stamer; R Vogel; E Thies; E Mandelkow; E-M Mandelkow
Journal:  J Cell Biol       Date:  2002-03-18       Impact factor: 10.539

View more
  22 in total

1.  Reproductive Stage and Modulation of Stress-Induced Tau Phosphorylation in Female Rats.

Authors:  Danielle Steinmetz; Eugenia Ramos; Shannon N Campbell; Teresa Morales; Robert A Rissman
Journal:  J Neuroendocrinol       Date:  2015-11       Impact factor: 3.627

2.  Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor.

Authors:  Shannon N Campbell; Cheng Zhang; Louise Monte; Allyson D Roe; Kenner C Rice; Yvette Taché; Eliezer Masliah; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation.

Authors:  Robert A Rissman; Michael A Staup; Allyson Roe Lee; Nicholas J Justice; Kenner C Rice; Wylie Vale; Paul E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.

Authors:  Shannon N Campbell; Cheng Zhang; Allyson D Roe; Nickey Lee; Kathleen U Lao; Louise Monte; Michael C Donohue; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 5.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 6.  A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.

Authors:  Matthew Barron; Jane Gartlon; Lee A Dawson; Peter J Atkinson; Marie-Christine Pardon
Journal:  Exp Gerontol       Date:  2016-12-12       Impact factor: 4.032

Review 7.  The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity.

Authors:  Juliane Obst; Emilie Simon; Renzo Mancuso; Diego Gomez-Nicola
Journal:  Front Aging Neurosci       Date:  2017-06-23       Impact factor: 5.750

8.  Effects of chronic noise on the corticotropin-releasing factor system in the rat hippocampus: relevance to Alzheimer's disease-like tau hyperphosphorylation.

Authors:  Zhihui Gai; Donghong Su; Yawen Wang; Wenlong Li; Bo Cui; Kang Li; Xiaojun She; Rui Wang
Journal:  Environ Health Prev Med       Date:  2017-12-11       Impact factor: 3.674

9.  Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport.

Authors:  Michelle H Le; April M Weissmiller; Louise Monte; Po Han Lin; Tia C Hexom; Orlangie Natera; Chengbiao Wu; Robert A Rissman
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

10.  Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A.

Authors:  Jin Liu; Ding Wang; Shu-Qin Li; Yang Yu; Richard D Ye
Journal:  J Neuroinflammation       Date:  2016-02-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.